| Liposome-based delivery of biological drugs KT Magar, GF Boafo, X Li, Z Chen, W He Chinese Chemical Letters 33 (2), 587-596, 2022 | 120 | 2022 |
| Approved nanomedicine against diseases Y Jia, Y Jiang, Y He, W Zhang, J Zou, KT Magar, H Boucetta, C Teng, ... Pharmaceutics 15 (3), 774, 2023 | 64 | 2023 |
| Multifunctional nanoparticle-mediated combining therapy for human diseases X Li, X Peng, M Zoulikha, GF Boafo, KT Magar, Y Ju, W He Signal transduction and targeted therapy 9 (1), 1, 2024 | 60 | 2024 |
| The role of cryoprotective agents in liposome stabilization and preservation GF Boafo, KT Magar, MD Ekpo, W Qian, S Tan, C Chen International journal of molecular sciences 23 (20), 12487, 2022 | 45 | 2022 |
| Metal phenolic network-stabilized nanocrystals of andrographolide to alleviate macrophage-mediated inflammation in-vitro KT Magar, GF Boafo, M Zoulikha, X Jiang, X Li, Q Xiao, X Xing, X Wang, ... Chinese Chemical Letters 34 (1), 107453, 2023 | 23 | 2023 |
| Thin layer chromatography based chemical profiling and antioxidant activity of selected Nepalese medicinal plants S Giri, U Giri, K Subedi, KT Magar, S Pant, KR Joshi J Health Allied Sci 10 (2), 15-22, 2020 | 12 | 2020 |
| Approved Nanomedicine against Diseases. Pharmaceutics 2023, 15, 774 Y Jia, Y Jiang, Y He, W Zhang, J Zou, KT Magar, H Boucetta, C Teng, ... | 2 | |
| Injectable long-acting formulations (ILAFs) and manufacturing techniques KT Magar, H Boucetta, Z Zhao, Y Xu, Z Liu, W He Expert opinion on drug delivery, 0 | | |
| Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes KT Magar | | |
